Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia
Authors:
Open Access
- 11 May 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 12, 296
Abstract
Objective: Abnormality of the immune system might play a significant role in the pathogenesis of schizophrenia. We want to identity whether the serum TNF-α and IL-1β levels were changed in FEDN patients and CP and to investigate the relationship between both cytokines and psychopathological symptoms. Methods: We recruited 69 FEDN patients, 87 CP and 61 healthy controls. Schizophrenia symptomatology was evaluated with the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Negative Symptoms (SANS) and Clinical Global Impression Scale (CGI). Serum TNF-α and IL-1β levels were examined using sandwich enzyme-linked immunosorbent assay (ELISA). Results: TNF-α and IL-1β levels in CP were significantly higher compared to healthy controls, but TNF-α and IL-1β levels in FEDN patients were significantly lower than in both CP and healthy controls. A moderate correlation between serum TNF-α or IL-1β levels and PANSS negative subscore was found in CP. But there was no correlation between altered cytokines and clinical symptoms in FEDN patients. Conclusions: Increased TNF-α and IL-1β levels in chronic patients may be associated with the progression, psychotropic drugs or other factors occur during chronic stage. Immune modulating treatments may become a new strategy of therapy for this subgroup of patients.Keywords
This publication has 39 references indexed in Scilit:
- Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophreniaSchizophrenia Research, 2016
- Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusersSchizophrenia Research, 2015
- The effects of the stress response on immune function in invertebrates: An evolutionary perspective on an ancient connectionHormones and Behavior, 2012
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parametersPsychopharmacology, 2012
- C-reactive protein serum level in drug-free male Egyptian patients with schizophreniaPsychiatry Research, 2011
- Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of SchizophreniaThe Journal of Neuroscience, 2008
- Neurodegeneration and InflammationNutrition in Clinical Practice, 2008
- Inflammation and schizophreniaExpert Review of Neurotherapeutics, 2007
- Cytokines in schizophrenia and the effects of antipsychotic drugsBrain, Behavior, and Immunity, 2006
- Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigraNeurobiology of Disease, 2006